Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy.
about
Endometriosis, angiogenesis and tissue factorAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadTargeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosisNovel therapies targeting endometriosisNatural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancerExpression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factorhI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer.Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expressionTissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging.Role of tissue factor in cancer.Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy.Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG miceMutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor.Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins.A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy.Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.Activation of hypoxia-inducible factor 1 attenuates periapical inflammation and bone loss.Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets.
P2860
Q27013803-5EFCCC92-1996-480D-A62D-5ED81C0B6705Q28397132-B9FACD2B-FA62-4F1A-8063-BB9F325E8D33Q30453862-49F3CCF7-74BC-46B0-A1A8-63F5C57E0026Q31131792-8DF93723-90FF-4BD9-8DBF-38E16E819F53Q33588136-7690B434-973E-48C2-AFE4-1D9FD1E6D74FQ33597282-73531C68-7CA1-4A58-AA21-4770A554D8F1Q33714186-5968FBF7-2F62-45C0-ACD9-BD013EC197A4Q33715830-5596EF1D-5E68-41DC-B95D-02AEF4044A02Q33938673-E58CA02C-0BB8-4C1B-9378-8989810AB0FAQ34253625-5D770AF9-76BD-4E3D-A8A7-AB0A8B2E4581Q34287997-28C56D08-F6E1-41DC-A02F-8EFE79E01D71Q35006931-1B47A283-EA98-453C-8D90-FA24DEE83E4FQ35117351-7A8D3342-7E8B-4B8E-B548-71B0F31F8695Q35800342-3BBD0F3F-E54D-4047-BA30-50039B0E8CB6Q36972097-EE31C644-F690-49AC-A619-7C174D5D7ABAQ37030520-6BA69919-D510-455C-B8E1-E9E7BA5537D8Q37211735-8CBB4D6D-BF02-4EFE-AE54-B121BDB14271Q37338189-1618F75A-D2B4-479B-92EE-572313C5AB82Q37393391-6B9BF022-8C7C-4079-BD1F-8E6AF0996C60Q37633792-E2BAAAEB-6AA8-4B48-BA12-62AAD44D53F2Q37639757-EBF23219-ABD0-4A0F-89A5-24663F18E3CCQ37641624-A35B8360-5CC2-496E-99A0-96F6AE4CB1D1Q37702117-51FE1F62-3259-4B09-879C-518AE7AB3865Q37705993-A1E6328B-2BAD-428D-9B25-147E7F9360F9Q39771845-486AD417-C03E-4F7C-B21F-E55F7049F1D7Q40573323-C0AB7B8C-B95D-45DC-9ED0-03A82543FCF6Q40696514-6F3D312D-4511-428C-818C-BCBE2616792FQ41113194-241CF60B-3BE2-4C65-AC7C-0E80B1745FF1Q41764457-A1237059-1E91-4C23-9271-6D209E8D0337Q52692695-AC942A6B-C691-4059-ACBE-A83B150C1564Q52721270-DB54FD38-2120-4E0B-A40A-8079F6709A9AQ54236077-78ADDBCB-0B00-407C-A7C8-3C1254E1266AQ54962618-DD8F8CCA-DDBE-43EC-98F6-4F4D2ED51EFA
P2860
Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@ast
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@en
type
label
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@ast
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@en
prefLabel
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@ast
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@en
P2860
P356
P1476
Intratumoral injection of aden ...... ates for cancer immunotherapy.
@en
P2093
P2860
P304
P356
10.1073/PNAS.97.16.9221
P407
P50
P577
2000-08-01T00:00:00Z